Kober T - Search Results

1

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis.

Schulz H, Bohlius JF, Trelle S, Skoetz N, Reiser M, Kober T, Schwarzer G, Herold M, Dreyling M, Hallek M, Engert A. Schulz H, et al. Among authors: kober t. J Natl Cancer Inst. 2007 May 2;99(9):706-14. doi: 10.1093/jnci/djk152. J Natl Cancer Inst. 2007. PMID: 17470738

2

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma.

Schulz H, Bohlius J, Skoetz N, Trelle S, Kober T, Reiser M, Dreyling M, Herold M, Schwarzer G, Hallek M, Engert A. Schulz H, et al. Among authors: kober t. Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003805. doi: 10.1002/14651858.CD003805.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943799 Free PMC article. Review.

3

Biannual report of the Cochrane Haematological Malignancies Group.

Trelle S, Higgins G, Kober T, Engert A. Trelle S, et al. Among authors: kober t. J Natl Cancer Inst. 2004 Aug 4;96(15):E2. doi: 10.1093/jnci/djh242. J Natl Cancer Inst. 2004. PMID: 15292394 No abstract available.

4

Second biannual report of the Cochrane Haematological Malignancies Group.

Kober T, Bohlius J, Trelle S, Engert A. Kober T, et al. J Natl Cancer Inst. 2005 Apr 6;97(7):E1. doi: 10.1093/jnci/dji125. J Natl Cancer Inst. 2005. PMID: 15812063 Review. No abstract available.

5

Third biannual report of the Cochrane Haematological Malignancies Group.

Kober T, Skoetz N, Trelle S, Bohlius J, Engert A; Cochrane Haematological Malignancies Group. Kober T, et al. J Natl Cancer Inst. 2005 Aug 17;97(16):E2. doi: 10.1093/jnci/dji258. J Natl Cancer Inst. 2005. PMID: 16106014 Review. No abstract available.

6

Fourth biannual report of the Cochrane Haematological Malignancies Group.

Kober T, Hülsewede H, Bohlius J, Engert A. Kober T, et al. J Natl Cancer Inst. 2006 Apr 19;98(8):E1. doi: 10.1093/jnci/djj156. J Natl Cancer Inst. 2006. PMID: 16622111 Review. No abstract available.

7

Reporting of randomized controlled trials in Hodgkin lymphoma in biomedical journals.

Kober T, Trelle S, Engert A. Kober T, et al. J Natl Cancer Inst. 2006 May 3;98(9):620-5. doi: 10.1093/jnci/djj160. J Natl Cancer Inst. 2006. PMID: 16670387 Free article.

8

[New horizons in evidence-based haematological oncology: outcome and importance of the scientific activities of the Cochrane Haematologicial Malignancies Group (CHMG)].

Kober T, Enger A. Kober T, et al. Z Arztl Fortbild Qualitatssich. 2006;100(3):167-73. Z Arztl Fortbild Qualitatssich. 2006. PMID: 16768081 German.

9

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D. Turner L, et al. Among authors: kober t. Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152285 Free PMC article. Review.

10

[Evidence-based oncology as a collective society problem].

Kober T. Kober T. Z Arztl Fortbild Qualitatssich. 2006;100(3):165-6. Z Arztl Fortbild Qualitatssich. 2006. PMID: 16768080 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters